Actinium Pharmaceuticals
ATNM
#9125
Rank
โ‚ฌ55.48 M
Marketcap
1,78ย โ‚ฌ
Share price
4.10%
Change (1 day)
-61.18%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -โ‚ฌ43.39 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.08 Million. In 2023 the company made an earning of -โ‚ฌ48.48 Million a decrease over its 2022 earnings that were of -โ‚ฌ31.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ43.39 Million-10.5%
2023 -โ‚ฌ48.48 Million52.24%
2022 -โ‚ฌ31.84 Million36.61%
2021 -โ‚ฌ23.31 Million11.48%
2020 -โ‚ฌ20.91 Million1.46%
2019 -โ‚ฌ20.61 Million-7.37%
2018 -โ‚ฌ22.25 Million-11.46%
2017 -โ‚ฌ25.13 Million10.67%
2016 -โ‚ฌ22.71 Million15.7%
2015 -โ‚ฌ19.63 Million-14.86%
2014 -โ‚ฌ23.05 Million129.19%
2013 -โ‚ฌ10.06 Million-8.55%
2012 -โ‚ฌ11 Million
2010 โ‚ฌ0 M-152.15%
2009 -โ‚ฌ0.02 Million-39.8%
2008 -โ‚ฌ0.03 Million120.29%
2007 -โ‚ฌ0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ34.73 Million-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.36 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ93.22 Million 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA